Axogen, Inc. to Participate at Jefferies Virtual London Healthcare Conference and Canaccord Genuity Virtual MedTech & Diagnostics Forum

Rhea-AI Summary

Axogen, Inc. (NASDAQ: AXGN) announced that its chairman and CEO, Karen Zaderej, will present at two investor events in November 2020. The first event, the Jefferies Virtual London Healthcare Conference, is scheduled for November 18 at 3:15 p.m. (10:15 a.m. ET). The second, the Canaccord Genuity Virtual MedTech & Diagnostics Forum, will take place on November 19 at 10:00 a.m. ET. Both presentations will be available via live webcast on the company's Investors page and will be archived for 90 days.

ALACHUA, Fla., Nov. 04, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, today announced that Karen Zaderej, chairman, CEO, and president, will present at two upcoming investor events – the Jefferies Virtual London Healthcare Conference and the Canaccord Genuity Virtual MedTech & Diagnostics Forum.

Ms. Zaderej will present at the Jefferies London Healthcare Conference on Wednesday, November 18, 2020 at 3:15 p.m. (10:15 a.m. ET).

She will present at the Canaccord Genuity Virtual MedTech & Diagnostics Forum on Thursday, November 19, 2020 at 10:00 a.m. ET.

Both presentations will be webcast live and accessible through the Investors page at www.axogeninc.com. For those not available to listen to the live broadcast, a replay will be archived for 90 days and available through the Investors page on www.axogeninc.com.

About Axogen
Axogen (AXGN) is the leading company focused specifically on the science, development and commercialization of technologies for peripheral nerve regeneration and repair. Axogen employees are passionate about helping to restore peripheral nerve function and quality of life to patients with physical damage or transection to peripheral nerves by providing innovative, clinically proven and economically effective repair solutions for surgeons and health care providers. Peripheral nerves provide the pathways for both motor and sensory signals throughout the body. Every day, people suffer traumatic injuries or undergo surgical procedures that impact the function of their peripheral nerves. Physical damage to a peripheral nerve, or the inability to properly reconnect peripheral nerves, can result in the loss of muscle or organ function, the loss of sensory feeling, or the initiation of pain.

Axogen's platform for peripheral nerve repair features a comprehensive portfolio of products, including Avance^® Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; Axoguard^® Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; Axoguard^® Nerve Protector, a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments; Axoguard^® Nerve Cap, a porcine submucosa ECM product used to protect a peripheral nerve end and separate the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and Avive^® Soft Tissue Membrane, a processed human umbilical cord intended for surgical use as a resorbable soft tissue barrier. The Axogen portfolio of products is available in the United States, Canada, the United Kingdom, South Korea, and several other European and international countries.

Contact:
Axogen, Inc.
Peter J. Mariani, chief financial officer
pmariani@axogeninc.com
InvestorRelations@axogeninc.com

FAQ

When is Karen Zaderej presenting at the Jefferies Virtual London Healthcare Conference?

Karen Zaderej will present at the Jefferies Virtual London Healthcare Conference on November 18, 2020, at 3:15 p.m. ET.

What is the date and time of the Canaccord Genuity Virtual MedTech & Diagnostics Forum presentation?

The presentation at the Canaccord Genuity Virtual MedTech & Diagnostics Forum is scheduled for November 19, 2020, at 10:00 a.m. ET.

How can I access the live webcast of Axogen's presentations?

The live webcast of Axogen's presentations can be accessed on their Investors page at www.axogeninc.com.

Will there be a replay of the Axogen presentations available?

Yes, a replay of the Axogen presentations will be available for 90 days after the event on their Investors page.

What is Axogen's focus in the medical field?

Axogen (AXGN) specializes in developing innovative surgical solutions for the repair and regeneration of peripheral nerves.